WO2010059527A2 - Système, dispositif et procédé de détection pour modulation de thérapie - Google Patents

Système, dispositif et procédé de détection pour modulation de thérapie Download PDF

Info

Publication number
WO2010059527A2
WO2010059527A2 PCT/US2009/064427 US2009064427W WO2010059527A2 WO 2010059527 A2 WO2010059527 A2 WO 2010059527A2 US 2009064427 W US2009064427 W US 2009064427W WO 2010059527 A2 WO2010059527 A2 WO 2010059527A2
Authority
WO
WIPO (PCT)
Prior art keywords
therapy
parameter
individual
indicator
related action
Prior art date
Application number
PCT/US2009/064427
Other languages
English (en)
Other versions
WO2010059527A3 (fr
Inventor
Angela Strand
Mark Zdeblick
George Savage
David O' Reilly
Original Assignee
Proteus Biomedical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Biomedical, Inc. filed Critical Proteus Biomedical, Inc.
Priority to EP09828058A priority Critical patent/EP2346391A4/fr
Priority to US12/665,695 priority patent/US20110196454A1/en
Priority to JP2011536525A priority patent/JP2012509103A/ja
Publication of WO2010059527A2 publication Critical patent/WO2010059527A2/fr
Publication of WO2010059527A3 publication Critical patent/WO2010059527A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36071—Pain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36132—Control systems using patient feedback

Definitions

  • the mammalian nervous system comprises a network of specialized cells, i.e., neurons, which communicate information about an organism's surroundings and itself.
  • the neurons of the nervous system are interconnected in complex arrangements and use electrochemical signals and neurotransmitters to transmit impulses from one neuron to the next.
  • the interaction of the different neurons form neural circuits that regulate the organism's perception of the world and activities associated with its body, thus regulating its behavior.
  • Conditions related to the nervous system may result in chronic and/or acute pain sensations.
  • Common chronic pain complaints include headache, low back pain, cancer pain, arthritis pain, neurogenic pain, and psychogenic pain.
  • a neural-related therapy such as neural stimulation/modulation
  • the therapy may electrically target a fixed tissue site. While this approach may generally focus on a neural region associated with the chronic pain, the approach may not be predicated on a fully-informed basis with respect to fundamental data.
  • the treatment may be generally applicable to a broad cross-section of individuals sharing common characteristics and condition parameter(s), the treatment, however, may not take into account the differing parameters or conditions specific to the individuals. Consequently, the treatment may not be able to meet the individual needs of a patient and optimize the therapy outcome of the patient.
  • Sensing methods for therapy modulation include applying a therapy-related action based on a therapy parameter sensed or received. Also provided are systems and devices that implement the methods in a variety of applications using different components.
  • Figure 1 illustrates a sensing system for therapy modulation in a patient therapy environment.
  • Figure 2 illustrates the sensing system for therapy modulation of Figure 1 in greater detail.
  • Figure 3 illustrates a device for therapy modulation.
  • Figure 4 illustrates a method for therapy modulation.
  • the invention provides a sensing method, system, and device for therapy modulation. More particularly, the invention includes use of one or more therapy parameters to enhance therapy.
  • the therapy involves neural-related treatment and/or treatment directed to a neural-related condition, e.g., therapy for pain management.
  • the therapy parameters used alone or in conjunction with various algorithms, effectuate various therapy outcomes by, for example, informing therapy adjustments, stimulating via a therapy program, and automatically modulating therapy dimensions.
  • the automatic modulation may be accomplished as a result of, or as a part of, a feedback system associated with the therapy parameter, e.g., a closed-loop feedback system based on the therapy parameter(s).
  • the therapy parameters may be tracked and stored.
  • the tracked and stored data are sometimes referred to herein as "historical data".
  • the historical data may be employed for various purposes. For example, the historical data may be displayed as longitudinal information.
  • the historical data may also be analyzed to determine an individual patient's "baseline” for therapy and response. Further, the historical data may be analyzed and modeled for effective program management, making recommendations, etc.
  • the therapy parameters may be used as bases for a modulated "tuning" program, i.e., a program that a patient, clinician, etc., may run on demand to intelligently modify the current therapy for enhanced results, etc.
  • the tuning program may prompt the patient for feedback (various therapy parameters) and, based on the feedback, adjust the therapy.
  • Other data e.g., objective therapy parameters, may be incorporated for adjustment calculations.
  • Use of the invention may have many areas of applications which include neural stimulation and/or neuromodulation (sometimes collectively referred to herein as "neural stimulation"), cardiac rhythm management, etc.
  • Certain aspects may include one or more sensors for sensing at least one therapy parameter.
  • the sensors may be extracorporeal, implanted, or both.
  • the sensors may be communicably, e.g., electrically, mechanically, etc., associated with a device such as an external device or an implanted device.
  • external devices include personal receivers, e.g., removably attachable receivers, such as those disclosed and described in PCT application serial nos. PCT/US2008/052845 published as WO/2008/095183 and PCT/US2006/016370 published as WO/2006/1 16718, the disclosures of which are herein incorporated by reference.
  • implantable medical device refers to a device configured to be positioned at least partially on a living body, at least partially in a living body, or a combination thereof.
  • the implantable medical device may include a lead having various electrode configurations communicably associated with controller circuitry, a power source, etc., and one or more sensors, e.g., a neural sensing, for sensing the therapy parameter.
  • the implantable medical device may comprise one or more leads with multiple in-line segmented electrode satellites, wherein each electrode is independently controllable and power/data wire(s) for multiplexing the multiple segmented electrode satellites.
  • PCT application no. PCT/US2003/039524 published as WO 2004/052182
  • PCT application no. PCT/US2005/031559 published as WO 2006/029090
  • PCT application no. PCT/US2005/04681 1 published as WO 2006/069322
  • PCT application no. PCT/US2005/046815 published as WO 2006/069323
  • PCT application no. PCT/US2006/048944 published as WO 2007/075974
  • United States application serial no. 1 1/939,524 published as US 2008-01 14230 A1 , the disclosures of which are herein incorporated by reference.
  • PCT/US2008/056296 published as WO/2008/1 12577; and PCT application serial no. PCT/US2008/056299 published as WO/2008/1 12578; as well as United States Provisional Application Serial Nos.: 61/1 14,433; 61/1 14,437; 61/1 15,887; 61/1 14,441 ; 61/1 14,442; and 61/1 14,443; the disclosures of which are herein incorporated by reference.
  • FIG. 1 illustrates a sensing system for therapy modulation 102 in a patient therapy environment 100.
  • the sensing system for therapy modulation 102 may be associated with, e.g., worn by, placed on, or implanted in, an individual, e.g., patient 104.
  • the sensing system 102 may communicably interoperate, via various vehicles of communication, e.g., communication device(s) 106, channels, and /or modes, with one or more persons, e.g., clinician 108, and one or more storage media, e.g., with database 110, etc.
  • the sensing system 102 may communicate via a variety of devices, modes, and combinations thereof, as discussed hereinafter.
  • FIG. 2 illustrates the sensing system for therapy modulation 102 of Figure 1 in greater detail.
  • the sensing system 102 may comprise, for example, a receive module 200 to receive a therapy parameter 202 and to forward a therapy parameter instruction 204 to a therapy-related action module 206, which is communicably coupled to the receive module 200.
  • the therapy-related action module 206 may effectuate, based on the therapy parameter instruction 204, a therapy-related action 208 associated with a patient's therapy.
  • the sensing system 102 may further comprise a remote sensing module 201 which may be communicably coupled to the receive module 200 to sense the therapy parameter 202.
  • the receive module 200 may comprise any hardware component, software, and/or device, and combinations thereof, capable of carrying out the functionality of receiving the therapy parameter 202 and further capable of the functionality necessary to generate and/or communicate, directly or indirectly, the therapy parameter instruction 204 to the therapy-related action module 206.
  • the receive module 200 may comprise circuitry, e.g., an integrated circuit, to receive a signal associated with the therapy parameter 202, and may further comprise a transmitter device to transmit the signal, directly or indirectly, to the therapy-related action module 206.
  • the receive module 200 may comprise or be integrated into a lead having a receiver and circuitry logic for receiving and processing the therapy parameter 202 and, based on the therapy parameter 202, generating the therapy parameter instruction 204 for transmission to the therapy-related action module 206.
  • the lead may further comprise multiple electrodes, e.g., sensing electrodes and stimulation electrodes.
  • the lead may be implanted in an area associated with neural activity in the patient 104, and may be capable of providing stimulation to areas of neural tissue via one or more of the electrodes.
  • the receive module 200 may have its associative sensing electrode(s) remotely, e.g., such as the remote sensing module 201.
  • the remote sensing module 201 may comprise one or more hardware and/or software components and is capable of carrying out the functionality of sensing, generating, and/or communicating the therapy parameter 202.
  • the remote sensing module 201 may be a cardiac device implanted in the patient 104, such as a cardiac rhythm device, which senses or measures a heart parameter, such as a heart rate of the patient, and communicates the heart rate to the receive module 200.
  • the receive module 200 may store, process, generate, transmit, etc. information containing the heart parameter for current and/or future informing purposes, etc. One example is to inform an algorithm or processing one or more steps employed in deciding the therapy parameter 202 or therapy parameter instruction 204.
  • the therapy parameter 202 may include any parameter associated with an individual, e.g., the patient 104, or an individual's therapy.
  • the therapy parameter 202 may include various categories of parameters associated with the individual, e.g., a physiologic parameter, a subjective parameter, a chemical parameter, an electrical parameter, etc.
  • the physiologic parameter may be heart rate, heart rate variability, an edema indicator, a fluid retention indicator, body temperature, a perspiration indicator, a galvanic skin response, blood pressure, a vasodilatation indicator, etc.
  • the subjective parameter may be a patient-perceived pain indicator (PPPI), a patient- perceived tolerance indicator (PPTI), and a patient perceived-optimal treatment indicator (PPOTI).
  • the chemical parameter may be an extracellular signal-regulated kinase (ERK), gamma-aminobutyric acid (GABA), acetylcholine (Ach), and a neural activity indicator.
  • the electrical parameter may be an indicator of a conduction pattern associated with the nervous system or other electrical indicator.
  • the therapy parameter 202 may be generated and sensed via a variety of means and devices.
  • the physiologic parameter may be sensed via one or more sensors, such as the remote sensing module 201 , embodied herein as cardiac sensing devices, fluid sensors, temperature sensors, chemical sensors, electrical sensors, etc.
  • the subjective parameters may be generated / obtained via various communication devices such as mobile telephones having associated applications which facilitate the patient 104 to input various qualitative and/or quantitative therapy- parameters, e.g., the PPPI, the PPTI, the PPOTI, etc.
  • the patient 104 may enter the PPPI, e.g., a scaled, numeric indicator of the patient's current perception of the degree or level of pain experienced.
  • the PPPI may be entered, for example, using an application on the patient's mobile telephone or computer. The application then may forward the therapy parameter 202 to the receive module 200 to effect the therapy-related action module 206.
  • the therapy parameter instruction 204 may be used to derive data pertinent to the therapy-related action 208 to be taken.
  • the therapy parameter instruction 204 comprises data, e.g., a data set, etc., communicated to and/or received by the therapy-related action module 206.
  • the therapy-related action module 206 may comprise any hardware component(s), software module(s), and/or device(s), and combinations thereof, capable of carrying out the functionality of receiving the therapy parameter instruction 204 and further capable of the functionality necessary to communicate, e.g., active or passive transfer, accessibility, etc. of the therapy parameter instruction 204 to effectuate the therapy-related action 208.
  • the therapy-related action module 206 may comprise circuitry, e.g., an integrated circuit, to receive a signal associated with the therapy parameter instruction 204, and may further comprise circuitry logic to carry out the therapy parameter instruction 204 to effectuate the therapy-related action 208.
  • the therapy-related action module 206 may be wholly or partially integrated, or otherwise associated with the receive module 200.
  • the therapy-related action module 206 and the receive module 200 may be part of a lead or other therapy-related device.
  • circuitry on a device e.g., a therapy device, may interpret the therapy parameter instruction 204 and cause the target of the therapy parameter instruction 204, e.g., the therapy device such as a neural stimulation device, to mechanically actuate a component to modulate therapy or to electrically effect one or more components of the therapy device to affect therapy, e.g., discontinue stimulation, increase intensity of the electrical field, adjust focus of an electrode, etc.
  • the therapy-related action module 206 may be independent of the receive module 200.
  • the therapy-related action module 206 may be a part of the lead, but the receive module 200 may be implemented remote from the lead.
  • the two devices may communicate, for example, via conduction associated with body fluid of the patient, radio frequency (RF) communications, or other means.
  • RF radio frequency
  • the therapy-related action 208 includes, initiating a therapy, modifying the therapy, stopping the therapy, discontinuing the therapy, informing the individual of the therapy, tracking the therapy parameter 202, storing the therapy parameter 202, displaying the therapy parameter 202, generating a baseline indication associated with the individual, e.g., the patient 104, displaying the baseline indication, generating an historical data model including the therapy parameter 202, determining a program based on at least one of the baseline indication and the historical data model, analyzing the therapy data, automatically recommending a therapy based on the analysis of the therapy data, automatically prompting the individual for feedback, and modifying the therapy based on the feedback.
  • At least one of the therapy parameter(s) 202, the therapy parameter instruction(s) 204, other data, or combinations thereof, may be stored/processed/displayed, etc., via various devices associated with, but not necessarily mechanically integrated with, at least one of the invention components.
  • a remote server having data storage and processing capabilities may utilize an application, e.g., the database 110 of Figure 1 , to interface with the system of the clinician 108, the communication device of the patient 104, or both.
  • Such devices may facilitate various aspects of the present invention, .e.g.., the server may store, analyze, process, etc., various therapy-related data for longitudinal display via, for example, the system of the clinician 108 or the communication device of the patient 104.
  • patient-entered therapy parameters may be communicated from a communication device associated with the patient 104 to the clinician's system, which may automatically (or with the clinician's intervention) process the received parameters in conjunction with, for example, various other patient data to generate a modulated treatment instruction, e.g., for automatic delivery via the patient's communication device to the therapy device, e.g., the lead.
  • the lead's circuitry effectuates a control, e.g., an increase, decrease, or no change, in stimulation intensity of the lead to enhance the patient's therapy and lower the patient's pain perception.
  • FIG. 3 illustrates a device for therapy modulation 300.
  • the device for therapy modulation 300 comprises at least one sensor 302 to sense at least one therapy parameter, e.g., the therapy parameter 202 of Figure 2, of an individual, such as the patient 104 of Figure 1 , and control logic circuitry 304 in electrical communication with the sensor 302 to receive the therapy parameter and to effect, based on the therapy parameter, a therapy-related action, e.g., the therapy-related action 208.
  • the device 300 is an implanted device, an implanted neural device, an extra-corporeal device, or a wearable device that can be actively-powered or passively-powered.
  • the device 300 further comprises one or more electrodes 306 to stimulate a tissue region 308 associated with the individual.
  • the electrodes 306 may be based on a network of electrodes.
  • the device 300 includes an integrated chip, which comprises the control logic circuitry 304, e.g., the receive module 200 and the therapy-related action module 206 of Figure 2 in combination, implemented on a lead 310.
  • the lead 310 also includes the electrodes 306 to stimulate the tissue region 308 and/or sense the therapy parameter, supra, as described in the incorporated reference(s).
  • the lead 310 may be implanted in the patient to effect a neural region, e.g., stimulate neural tissue to conduct a signal of interest, block a signal of interest, etc., as desired.
  • properties of the electrodes 306 may be controllably variable.
  • at least one electrode of the device 300 may be set to be voltage
  • at least one electrode of the device 300 may be set to be current
  • at least one electrode may be set to be an opposite current of the current. Examples of devices appropriate to such configuration are disclosed and described in United States provisional application serial no. 61/1 14,441 ; the disclosure of which is herein incorporated by reference.
  • FIG. 4 illustrates a method for therapy modulation.
  • a therapy parameter e.g., the therapy parameter 202 of Figure 2 associated with an individual, e.g., the patient 104
  • a therapy instruction e.g., the therapy instruction 204
  • a therapy-related action e.g., the therapy-related action 208
  • the method may include various other steps, e.g., sensing a therapy parameter using a sensor, e.g., a local or remote sensor; transmitting the therapy parameter, etc.
  • Communication-related modes include manual, wired, and wireless, etc.
  • Wireless technologies include radio signals, such as x-rays, ultraviolet light, the visible spectrum, infrared, microwaves, and radio waves, etc.
  • Wireless services include voice and messaging, handheld and other Internet-enabled devices, data networking, etc.
  • Vehicles of communication include the Internet, wired channels, wireless channels, communication devices including telephones, computers, wire, radio, optical or other electromagnetic channels, and combinations thereof, including other devices and/or components capable of/associated with communicating data.
  • the communication environments include in-body communications; various devices; various modes of communications such as wireless communications, wired communications, and combinations of the same, etc.
  • In-body communications include any communication of data or information via the body, i.e., communication via or associated with inter-body aspects, intra-body aspects, and a combination of the same.
  • inter-body aspects include communications associated with devices designed to attach to a body surface.
  • Intra- body aspects include communications associated with data generated from within the body, e.g., by the body itself or by a device implanted, ingested, or otherwise locatable in, or partially in, the body.
  • Communications include and/or may be associated with software, hardware, circuitry, various devices, and combinations thereof.
  • the devices include devices associated with therapy parameter, transmission, reception, communication, etc.
  • the devices further include various implantable, ingestible, insertable, and / or attachable devices associated with the human body or other living organisms.
  • the devices further include multimedia devices such as telephones, stereos, audio players, PDA's, handheld devices, and multimedia players.
  • Wireless communication modes include any mode of communication between points that utilizes, at least in part, wireless technology including various protocols and combinations of protocols associated with wireless transmission, data, and devices.
  • the points include, for example, wireless devices such as wireless headsets; audio and multimedia devices and equipment, such as audio players and multimedia players; telephones, including mobile telephones and cordless telephones; and computers and computer-related devices and components, such as printers.
  • Wired communication modes include any mode of communication between points that utilizes wired technology including various protocols and combinations of protocols associated with wired transmission, data, and devices.
  • the points include, for example, devices such as audio and multimedia devices and equipment, such as audio players and multimedia players; telephones, including mobile telephones and cordless telephones; and computers and computer-related devices and components, such as printers.
  • Devices include, for example, any device capable of receiving, storing, and or transmitting the therapy parameters. Examples of such devices include a mobile telephone, personal digital assistant (PDA), computer, etc.
  • Communication modes include any mode, channel, etc., capable of facilitating transmission, receipt, storage, etc. of the therapy parameter. Examples of communication modes include wired, wireless, etc.
  • One or more aspects of the subject invention may be in the form of computer readable media having programming stored thereon for implementing the various methods, or various steps thereof.
  • the computer readable media may be, for example, in the form of a computer disk or CD, a floppy disc, a magnetic "hard card", a server, or any other computer readable media capable of containing data or the like, stored electronically, magnetically, optically or by other means.
  • stored programming embodying steps for carrying-out the subject methods may be transferred or communicated to a processor, e.g., by using a computer network, server, or other interface connection, e.g., the Internet, or other relay means.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Primary Health Care (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

L'invention concerne un système, dispositif et procédé de détection pour modulation de thérapie. Divers aspects comportent un module de réception et un module d’action lié à la thérapie. Le module de réception permet de recevoir le paramètre de thérapie d'un individu. Le module d’action lié à la thérapie permet de réaliser, sur la base du paramètre de thérapie, une action liée à la thérapie associée au système nerveux de l'individu.
PCT/US2009/064427 2008-11-18 2009-11-13 Système, dispositif et procédé de détection pour modulation de thérapie WO2010059527A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP09828058A EP2346391A4 (fr) 2008-11-18 2009-11-13 Système, dispositif et procédé de détection pour modulation de thérapie
US12/665,695 US20110196454A1 (en) 2008-11-18 2009-11-13 Sensing system, device, and method for therapy modulation
JP2011536525A JP2012509103A (ja) 2008-11-18 2009-11-13 療法調整のための感知システム、デバイス、および方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11590208P 2008-11-18 2008-11-18
US61/115,902 2008-11-18

Publications (2)

Publication Number Publication Date
WO2010059527A2 true WO2010059527A2 (fr) 2010-05-27
WO2010059527A3 WO2010059527A3 (fr) 2010-08-12

Family

ID=42198754

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/064427 WO2010059527A2 (fr) 2008-11-18 2009-11-13 Système, dispositif et procédé de détection pour modulation de thérapie

Country Status (4)

Country Link
US (1) US20110196454A1 (fr)
EP (1) EP2346391A4 (fr)
JP (1) JP2012509103A (fr)
WO (1) WO2010059527A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013182493A (ja) * 2012-03-02 2013-09-12 Nec Corp メンタルケア支援システム、装置、方法およびプログラム

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3173125B1 (fr) 2008-07-30 2019-03-27 Ecole Polytechnique Fédérale de Lausanne Appareil de stimulation optimisée d'une cible neurologique
EP3563902B1 (fr) 2008-11-12 2021-07-14 Ecole Polytechnique Fédérale de Lausanne Dispositif de neurostimulation microfabriqué
EP2506920B1 (fr) 2009-12-01 2016-07-13 Ecole Polytechnique Fédérale de Lausanne Dispositif de neurostimulation surfacique microfabriqué et procédé de fabrication correspondant
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9549708B2 (en) 2010-04-01 2017-01-24 Ecole Polytechnique Federale De Lausanne Device for interacting with neurological tissue and methods of making and using the same
WO2015112603A1 (fr) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Produit ingérable pouvant être mâché et système de communication associé
JP6498177B2 (ja) 2013-03-15 2019-04-10 プロテウス デジタル ヘルス， インコーポレイテッド 本人認証装置システムおよび方法
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
CN105307719B (zh) 2013-05-30 2018-05-29 格雷厄姆·H.·克雷西 局部神经刺激仪
CA2965941C (fr) 2013-09-20 2020-01-28 Proteus Digital Health, Inc. Procedes, dispositifs et systemes de reception et de decodage de signal en presence de bruit a l'aide de tranches et d'une distorsion
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US10966620B2 (en) 2014-05-16 2021-04-06 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
WO2017134587A1 (fr) 2016-02-02 2017-08-10 Aleva Neurotherapeutics, Sa Traitement de maladies auto-immunes par stimulation cérébrale profonde
JP2021510608A (ja) 2017-11-07 2021-04-30 ニューロスティム オーエービー インコーポレイテッド 適応回路を有する非侵襲性神経アクティベーター
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
CA3144957A1 (fr) 2019-06-26 2020-12-30 Neurostim Technologies Llc Activateur de nerf non invasif a circuit adaptatif
JP2023506713A (ja) 2019-12-16 2023-02-20 ニューロスティム テクノロジーズ エルエルシー 昇圧電荷送達を用いた非侵襲性神経アクティベータ

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642008A (en) * 1968-09-25 1972-02-15 Medical Plastics Inc Ground electrode and test circuit
US3719183A (en) * 1970-03-05 1973-03-06 H Schwartz Method for detecting blockage or insufficiency of pancreatic exocrine function
ZA755785B (en) * 1974-10-07 1976-08-25 Baxter Laboratories Inc Diagnostic electrode assembly
US4077397A (en) * 1974-10-07 1978-03-07 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US4635641A (en) * 1985-10-16 1987-01-13 Murray Electronics Associates Limited Multi-element electrode
US5281287A (en) * 1989-07-21 1994-01-25 Iomed, Inc. Method of making a hydratable bioelectrode
US6749122B1 (en) * 1990-05-25 2004-06-15 Broadcom Corporation Multi-level hierarchial radio-frequency system communication system
US5394882A (en) * 1993-07-21 1995-03-07 Respironics, Inc. Physiological monitoring system
DE4329898A1 (de) * 1993-09-04 1995-04-06 Marcus Dr Besson Kabelloses medizinisches Diagnose- und Überwachungsgerät
US5400784A (en) * 1993-10-15 1995-03-28 Case Western Reserve University Slowly penetrating inter-fascicular nerve cuff electrode and method of using
US5724984A (en) * 1995-01-26 1998-03-10 Cambridge Heart, Inc. Multi-segment ECG electrode and system
US5868136A (en) * 1996-02-20 1999-02-09 Axelgaard Manufacturing Co. Ltd. Medical electrode
US5873849A (en) * 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US6024702A (en) * 1997-09-03 2000-02-15 Pmt Corporation Implantable electrode manufactured with flexible printed circuit
US6038464A (en) * 1998-02-09 2000-03-14 Axelgaard Manufacturing Co., Ltd. Medical electrode
US6477424B1 (en) * 1998-06-19 2002-11-05 Medtronic, Inc. Medical management system integrated programming apparatus for communication with an implantable medical device
US7209787B2 (en) * 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US6708060B1 (en) * 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
US6358202B1 (en) * 1999-01-25 2002-03-19 Sun Microsystems, Inc. Network for implanted computer devices
US6200265B1 (en) * 1999-04-16 2001-03-13 Medtronic, Inc. Peripheral memory patch and access method for use with an implantable medical device
ATE256421T1 (de) * 1999-05-25 2004-01-15 Medicotest As Hautelektrode
US6307468B1 (en) * 1999-07-20 2001-10-23 Avid Identification Systems, Inc. Impedance matching network and multidimensional electromagnetic field coil for a transponder interrogator
US6526034B1 (en) * 1999-09-21 2003-02-25 Tantivy Communications, Inc. Dual mode subscriber unit for short range, high rate and long range, lower rate data communications
US6654642B2 (en) * 1999-09-29 2003-11-25 Medtronic, Inc. Patient interactive neurostimulation system and method
US6990082B1 (en) * 1999-11-08 2006-01-24 Intel Corporation Wireless apparatus having a transceiver equipped to support multiple wireless communication protocols
US6882881B1 (en) * 1999-10-19 2005-04-19 The Johns Hopkins University Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders
US6708064B2 (en) * 2000-02-24 2004-03-16 Ali R. Rezai Modulation of the brain to affect psychiatric disorders
US6526315B1 (en) * 2000-03-17 2003-02-25 Tanita Corporation Portable bioelectrical impedance measuring instrument
US6496705B1 (en) * 2000-04-18 2002-12-17 Motorola Inc. Programmable wireless electrode system for medical monitoring
US6680923B1 (en) * 2000-05-23 2004-01-20 Calypso Wireless, Inc. Communication system and method
GB0014855D0 (en) * 2000-06-16 2000-08-09 Isis Innovation Combining measurements from different sensors
GB0014854D0 (en) * 2000-06-16 2000-08-09 Isis Innovation System and method for acquiring data
US7009946B1 (en) * 2000-06-22 2006-03-07 Intel Corporation Method and apparatus for multi-access wireless communication
US6871099B1 (en) * 2000-08-18 2005-03-22 Advanced Bionics Corporation Fully implantable microstimulator for spinal cord stimulation as a therapy for chronic pain
US7685005B2 (en) * 2000-08-29 2010-03-23 Medtronic, Inc. Medical device systems implemented network scheme for remote patient management
DE60102331T2 (de) * 2000-09-08 2005-03-17 Matsushita Electric Works, Ltd., Kadoma Datenübertragungssystem unter Verwendung eines menschlichen Körpers als Signalübertragungsweg
WO2002027659A2 (fr) * 2000-09-26 2002-04-04 Advantage 3D Llc Procede et systeme de la production, de stockage et de distribution de vues d'objets multi-directionnelles
US7160258B2 (en) * 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US8934968B2 (en) * 2001-08-03 2015-01-13 Cardiac Pacemakers, Inc. Neurostimulation and coronary artery disease treatment
US6999819B2 (en) * 2001-08-31 2006-02-14 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US6840904B2 (en) * 2001-10-11 2005-01-11 Jason Goldberg Medical monitoring device and system
US7010356B2 (en) * 2001-10-31 2006-03-07 London Health Sciences Centre Research Inc. Multichannel electrode and methods of using same
US7286878B2 (en) * 2001-11-09 2007-10-23 Medtronic, Inc. Multiplexed electrode array extension
US6993384B2 (en) * 2001-12-04 2006-01-31 Advanced Bionics Corporation Apparatus and method for determining the relative position and orientation of neurostimulation leads
GB0130010D0 (en) * 2001-12-14 2002-02-06 Isis Innovation Combining measurements from breathing rate sensors
US7016648B2 (en) * 2001-12-18 2006-03-21 Ixi Mobile (Israel) Ltd. Method, system and computer readable medium for downloading a software component to a device in a short distance wireless network
AU2003210752A1 (en) * 2002-02-01 2003-09-02 The Cleveland Clinic Foundation Modulation of the pain circuitry to affect chronic pain
US20040039417A1 (en) * 2002-04-16 2004-02-26 Medtronic, Inc. Electrical stimulation and thrombolytic therapy
US7184840B2 (en) * 2002-04-22 2007-02-27 Medtronic, Inc. Implantable lead with isolated contact coupling
US7076292B2 (en) * 2002-04-25 2006-07-11 Medtronic, Inc. Optical communication of neurostimulation-system information
US20040015205A1 (en) * 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US7181288B1 (en) * 2002-06-24 2007-02-20 The Cleveland Clinic Foundation Neuromodulation device and method of using the same
US7020508B2 (en) * 2002-08-22 2006-03-28 Bodymedia, Inc. Apparatus for detecting human physiological and contextual information
GB2393356B (en) * 2002-09-18 2006-02-01 E San Ltd Telemedicine system
US7736309B2 (en) * 2002-09-27 2010-06-15 Medtronic Minimed, Inc. Implantable sensor method and system
US6842636B2 (en) * 2002-09-27 2005-01-11 Axelgaard Manufacturing Co., Ltd. Medical electrode
SE0203108D0 (en) * 2002-10-22 2002-10-22 Siemens Elema Ab Multi-Electrode Catheter
WO2004041352A1 (fr) * 2002-10-31 2004-05-21 Medtronic, Inc. Systeme distribue de programmation therapeutique de neurostimulation
US7653031B2 (en) * 2003-03-05 2010-01-26 Timothy Gordon Godfrey Advance notification of transmit opportunities on a shared-communications channel
GB0308467D0 (en) * 2003-04-11 2003-05-21 Rolls Royce Plc Method and system for analysing tachometer and vibration data from an apparatus having one or more rotary components
FI116117B (fi) * 2003-04-17 2005-09-30 Polar Electro Oy Mittalaite ja menetelmä sykkeen mittaamiseksi sekä mittalaitteen valmistusmenetelmä
JP2007527737A (ja) * 2003-07-16 2007-10-04 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 人の生理状態をモニターするようになっているポータブル電子装置および健康管理システム
US7333857B2 (en) * 2003-07-18 2008-02-19 Arcl, Inc. Treatment of pain
US7174218B1 (en) * 2003-08-12 2007-02-06 Advanced Bionics Corporation Lead extension system for use with a microstimulator
CA2539547A1 (fr) * 2003-08-20 2005-03-03 Philometron, Inc. Controle d'hydratation
US20050062644A1 (en) * 2003-09-08 2005-03-24 Leci Jonathan Ilan Capsule device to identify the location of an individual
JP4153852B2 (ja) * 2003-09-18 2008-09-24 オリンパス株式会社 エネルギー供給用コイルおよびこれを用いた無線型被検体内情報取得システム
EP1711222A4 (fr) * 2003-12-19 2011-02-09 Savacor Inc Electrode numerique de gestion du rythme cardiaque
US7647112B2 (en) * 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
WO2005082453A1 (fr) * 2004-02-25 2005-09-09 Advanced Neuromodulation Systems, Inc. Systeme et procede permettant d'effectuer une stimulation neurologique de nerfs peripheriques pour traiter une lombalgie
JP4520198B2 (ja) * 2004-04-07 2010-08-04 オリンパス株式会社 被検体内位置表示システム
WO2005110238A1 (fr) * 2004-05-16 2005-11-24 Medic4All A.G Procede et dispositif pour mesurer des parametres physiologiques au niveau de la main
US7125382B2 (en) * 2004-05-20 2006-10-24 Digital Angel Corporation Embedded bio-sensor system
JP5186208B2 (ja) * 2004-05-28 2013-04-17 ジェート、ジャン ドゥ 確認装置および確認システム
JP4462614B2 (ja) * 2004-07-05 2010-05-12 ソニー・エリクソン・モバイルコミュニケーションズ株式会社 近距離無線通信システム、携帯端末装置および無線通信装置
US20060020297A1 (en) * 2004-07-20 2006-01-26 Gerber Martin T Neurostimulation system with distributed stimulators
WO2006008740A1 (fr) * 2004-07-21 2006-01-26 Aerotel Medical Systems (1998) Ltd. Dispositif portable, systeme et procede de mesure de parametres physiologiques et/ou environnementaux
WO2006029090A2 (fr) * 2004-09-02 2006-03-16 Proteus Biomedical, Inc. Methodes et appareil d'activation et de surveillance de tissus
US7450993B2 (en) * 2004-09-08 2008-11-11 Spinal Modulation, Inc. Methods for selective stimulation of a ganglion
US20070016089A1 (en) * 2005-07-15 2007-01-18 Fischell David R Implantable device for vital signs monitoring
CN100471445C (zh) * 2005-08-01 2009-03-25 周常安 贴片式生理监测装置
US20070198066A1 (en) * 2005-11-03 2007-08-23 Greenberg Robert J Method and apparatus for visual neural stimulation
US20100049006A1 (en) * 2006-02-24 2010-02-25 Surendar Magar Medical signal processing system with distributed wireless sensors
US7715920B2 (en) * 2006-04-28 2010-05-11 Medtronic, Inc. Tree-based electrical stimulator programming
US20080046038A1 (en) * 2006-06-26 2008-02-21 Hill Gerard J Local communications network for distributed sensing and therapy in biomedical applications
US7962174B2 (en) * 2006-07-12 2011-06-14 Andrew Llc Transceiver architecture and method for wireless base-stations
US20080021521A1 (en) * 2006-07-18 2008-01-24 Cardiac Pacemakers, Inc. Implantable Medical Device Communication System
US20080039916A1 (en) * 2006-08-08 2008-02-14 Olivier Colliou Distally distributed multi-electrode lead
US8852172B2 (en) * 2006-11-21 2014-10-07 Medimetrics Personalized Drug Delivery Ingestible electronic capsule and in vivo drug delivery or diagnostic system
GB0624085D0 (en) * 2006-12-01 2007-01-10 Oxford Biosignals Ltd Biomedical signal analysis method
US8412293B2 (en) * 2007-07-16 2013-04-02 Optiscan Biomedical Corporation Systems and methods for determining physiological parameters using measured analyte values
US20080300572A1 (en) * 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
US20090024184A1 (en) * 2007-07-17 2009-01-22 Nurotron Biotechnology, Inc. Cochlear implant utilizing multiple-resolution current sources and flexible data encoding
US8340750B2 (en) * 2007-07-19 2012-12-25 Medtronic, Inc. Mechanical function marker channel for cardiac monitoring and therapy control
KR101080423B1 (ko) * 2007-08-03 2011-11-04 삼성전자주식회사 멀티모듈결합형 휴대전자장치
US20090048498A1 (en) * 2007-08-17 2009-02-19 Frank Riskey System and method of monitoring an animal

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP2346391A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013182493A (ja) * 2012-03-02 2013-09-12 Nec Corp メンタルケア支援システム、装置、方法およびプログラム

Also Published As

Publication number Publication date
US20110196454A1 (en) 2011-08-11
EP2346391A4 (fr) 2012-08-15
EP2346391A2 (fr) 2011-07-27
WO2010059527A3 (fr) 2010-08-12
JP2012509103A (ja) 2012-04-19

Similar Documents

Publication Publication Date Title
US20110196454A1 (en) Sensing system, device, and method for therapy modulation
US11266842B2 (en) Use of a dedicated remote control as an intermediary device to communicate with an implantable medical device
US20150360038A1 (en) Heads-Up Display and Control of an Implantable Medical Device
US20170259072A1 (en) System architecture for medical implant
US11826570B2 (en) Adaptive chronic pain relief via implanted electrical neurostimulation
EP3918824A1 (fr) Établissement d'une liaison de communication sécurisée entre un dispositif implantable et un ou plusieurs dispositifs externes
US10049184B2 (en) Software application transmission via body interface using a wearable device in conjunction with removable body sensor arrays system and method
US20160274752A1 (en) Optical Head-Mounted Display for Controlling an Implantable Medical Device and Communication Accessory Attachable Thereto
US9731140B1 (en) Controller interface for an implantable stimulator device
US20120078132A1 (en) Method and Apparatus of Neural Signal Determination and Therapy Enhancement
US20200016408A1 (en) Controller interface for an implantable stimulator device
Wu The perspective of biomedical electronics
US20240136050A1 (en) Customizable neuromodulation device treatment journey
US20240131337A1 (en) Goal setting and tracking for neuromodulation treatment
US20230364421A1 (en) Parameter optimization based on different degrees of focusing
US20210361969A1 (en) Systems and methods for therapy delivery using near field magnetic induction devices
US10632314B1 (en) User interface for a patient user to adjust settings on an implantable device
WO2024084333A1 (fr) Techniques de mesure de l'épaisseur d'un lambeau de peau à l'aide d'ultrasons
CN117914020A (zh) 无线充电认证方法、设备、体外充电***及存储介质
WO2024015240A1 (fr) Automatisation d'une thérapie de stimulation par bolus à partir d'une utilisation apprise
WO2023126756A1 (fr) Réduction adaptative du bruit en fonction des préférences de l'utilisateur
CN116881875A (zh) 医疗***及其时序同步设备、存储介质、程序产品

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 12665695

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09828058

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2009828058

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011536525

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE